Matches in Nanopublications for { ?s ?p "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 28 of
28
with 100 items per page.
- NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_provenance.
- NP180720.RAS3YO8B7VG9URKNsFdNMPQbP2KO97PIQBea2S1a_5ctk130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180720.RAS3YO8B7VG9URKNsFdNMPQbP2KO97PIQBea2S1a_5ctk130_provenance.
- NP587212.RAZRiAU4wrFvdPiybP0jUeqTsjbsOkOKVfY-Q-dfVx5LY130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587212.RAZRiAU4wrFvdPiybP0jUeqTsjbsOkOKVfY-Q-dfVx5LY130_provenance.
- NP489809.RAH1jRTwl8POz_j0Y0CAYKEcygh-2uyK695cjRFSuwneI130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP489809.RAH1jRTwl8POz_j0Y0CAYKEcygh-2uyK695cjRFSuwneI130_provenance.
- assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1069193.RAfYzUhOQZpElLkngu2NORxNRC5E3A6j-GuCosaYuudZQ130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069193.RAfYzUhOQZpElLkngu2NORxNRC5E3A6j-GuCosaYuudZQ130_provenance.
- NP1069194.RAW8axcTwby9GP5-dOwGgO6YmZEhJiLzBs7OwS5zfQHL4130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069194.RAW8axcTwby9GP5-dOwGgO6YmZEhJiLzBs7OwS5zfQHL4130_provenance.
- NP1069195.RAYovMfPG77wy2ZgI9Z7IYdmaWdZsvlgh25Sn0t0zRUvk130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069195.RAYovMfPG77wy2ZgI9Z7IYdmaWdZsvlgh25Sn0t0zRUvk130_provenance.
- NP1069199.RAYMucSgwZ4w3vi_5uIG__-FUPIayV3QwQB_vBAHpDnVw130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069199.RAYMucSgwZ4w3vi_5uIG__-FUPIayV3QwQB_vBAHpDnVw130_provenance.
- NP1069191.RApZAHIkCPugXKiOjwsEyXV65Y2bbrJB6bYoXzD6h_ibA130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069191.RApZAHIkCPugXKiOjwsEyXV65Y2bbrJB6bYoXzD6h_ibA130_provenance.
- NP621727.RAF-sf0fwb9OJP0PAGdrjAx1ZPJRmqLFfvggL9cmOMTyw130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621727.RAF-sf0fwb9OJP0PAGdrjAx1ZPJRmqLFfvggL9cmOMTyw130_provenance.
- NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_provenance.
- NP625427.RALOTA0EseNG5gb0ILPW8DCmhztGAtfKi5nlEMIkiwg6o130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625427.RALOTA0EseNG5gb0ILPW8DCmhztGAtfKi5nlEMIkiwg6o130_provenance.
- NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621642.RA-aMonYWorf2RVlYYNkGKe2wPsLKggwnVllCrY2M1HPw130_provenance.
- NP622893.RA4y0whaWYRrssF86NcYPdlWA0FfgR5lOrH9GDXL0TKb4130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622893.RA4y0whaWYRrssF86NcYPdlWA0FfgR5lOrH9GDXL0TKb4130_provenance.
- NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_provenance.
- NP624287.RAwc5oTrVW5Lbhmax7to8N0qnd1PpfBXjgweXTikpyBqw130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624287.RAwc5oTrVW5Lbhmax7to8N0qnd1PpfBXjgweXTikpyBqw130_provenance.
- NP625348.RAwcPr4Wjg3yHsxGABfU8c9p-Ws4MNXgfFW8IQGcPFJFk130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625348.RAwcPr4Wjg3yHsxGABfU8c9p-Ws4MNXgfFW8IQGcPFJFk130_provenance.
- NP1069187.RAzK8VlMc9OTZFaXwzR22bOxFktbSk8jG2jHwhomClseE130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069187.RAzK8VlMc9OTZFaXwzR22bOxFktbSk8jG2jHwhomClseE130_provenance.
- NP1069189.RA8AUN0nR45x-PAefmgw_OKcDtVYTI4vHJH6KQZUaBIys130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069189.RA8AUN0nR45x-PAefmgw_OKcDtVYTI4vHJH6KQZUaBIys130_provenance.
- NP1069201.RA0ZrwJ452nOMHy8kLuzT4fUeVbKz6oKVP0LtucOC7RZk130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069201.RA0ZrwJ452nOMHy8kLuzT4fUeVbKz6oKVP0LtucOC7RZk130_provenance.